University of California San Francisco
Give to UCSF
UCSF scientists have formed a research alliance with pharmaceutical firm Eli Lilly and Company aimed at better understanding autoimmune diseases and fostering the development of new therapies
The level of trauma the women had experienced in childhood was associated with the age of their epigenetic clocks.
Tissue biologist Sarah Knox has long been fascinated with saliva. Just when she begins to doubt whether her singular passion will lead to real-world impact, an old family friend reaches out to her with a problem only she may be able to solve.
We turned to UCSF scientists to better understand probiotics and the human microbiome they aim to influence.
Many cancer patients might respond better to treatments with the help of a new prognostic indicator based on a distinctive pattern of gene activity within tumor cells.
Millie Hughes-Fulford, a UCSF scientist who flew in June 1991 aboard the first space shuttle mission dedicated to biomedical studies, died on Feb. 2 at the age of 75. S
Susan Acton discovered ACE2 while searching for new cardiovascular drugs. Decades later, she was surprised to see it popping up in the news once COVID took hold.
A new study finds that inherited genetic variation plays a role in who is likely to benefit from checkpoint inhibitors, which release the immune system’s brakes so it can attack cancer.
The new Institute will bring together scientists and clinicians from all UCSF sites to address the most critical questions related to the science of aging.
The camp was co-founded by Arthur Ablin, MD, the former chief of pediatric oncology at UCSF.
A new study of autism risk genes by UCSF and UC Berkeley scientists implicates disruption in prenatal neurogenesis – a process in which specialized “progenitor” cells give rise to new brain cells – in the development of autism spectrum disorders.
